Internal Medicine, Hematology · Louisville, KY
NPI
1407844574
Since 2005
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
529 S Jackson St
Louisville, KY, 40202
Phone (502) 562-4363
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
609 services
Medicare patients, 2024
146
Average age 71
Drug cost, 2024
$2.7M
470 prescriptions
Company payments, 2025
$1,469
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert V Emmons was code 99233 (hospital e&m - subsequent), 198 times for 43 patients. In total Robert V Emmons billed 609 services in 17 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 198 | 43 | $87.67 | $17K |
| 99214 Office E&M - Established | Facility | 169 | 74 | $69.06 | $12K |
| 99215 Office E&M - Established | Facility | 123 | 58 | $100.61 | $12K |
| 99205 Office E&M - New | Facility | 33 | 33 | $134.94 | $4,453 |
| 99223 Hospital E&M - Initial | Facility | 27 | 19 | $128.80 | $3,478 |
| 38222 Other Organ Systems | Facility | 19 | 16 | $51.89 | $986 |
| 99239 Hospital Discharge Management | Facility | 16 | 15 | $84.52 | $1,352 |
By year: 2022 $59K for 645 services; 2023 $56K for 632 services; 2024 $54K for 609 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert V Emmons prescribed most often to Medicare patients was Acyclovir, with 50 prescriptions and refills. In total Robert V Emmons wrote 470 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 50 | 63 | 18 | $542 |
| Revlimid Lenalidomide | 42 | 42 | Under 11 | $687K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 38 | 45 | 12 | $103 |
| Pomalyst Pomalidomide | 24 | 24 | Under 11 | $564K |
| Dexamethasone Generic | 20 | 21 | Under 11 | $327 |
| Hydroxyurea Generic | 19 | 21 | Under 11 | $242 |
| Prochlorperazine Maleate Generic | 18 | 18 | Under 11 | $198 |
| Brukinsa Zanubrutinib | 14 | 14 | Under 11 | $212K |
| Thalomid Thalidomide | 13 | 13 | Under 11 | $178K |
| Ninlaro Ixazomib Citrate | 13 | 13 | Under 11 | $164K |
| Bosulif Bosutinib | 12 | 12 | Under 11 | $227K |
| Venclexta Venetoclax | 11 | 11 | Under 11 | $96K |
Brand drugs: 182 claims; generic drugs: 288 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert V Emmons $1,469 ($1,469 in general payments such as food, travel and fees) from 23 companies. The largest payer was GlaxoSmithKline, LLC. with $231.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 8 | $231 |
| Astellas Pharma US Inc 4503.T | 8 | $185 |
| Amgen Inc. AMGN | 1 | $126 |
| Celgene Corporation BMY | 5 | $113 |
| Adaptive Biotechnologies Corporation ADPT | 2 | $95.62 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $83.42 |
| Incyte Corporation INCY | 3 | $75.83 |
| Genzyme Corporation SNY | 3 | $62.98 |
| Abbvie Inc. ABBV | 3 | $60.63 |
| Legend Biotech USA Inc. LEGN | 3 | $59.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.